| Name | BRL 37344 sodium salt hydrate |
|---|---|
| Synonyms | sodium,2-[4-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]acetate |
| Description | BRL 37344 sodium (BRL 37344A) is a specific β3-adrenergic receptor agonist. BRL 37344 sodium treatment significantly lowers the body weight of obese mice[1]. |
|---|---|
| Related Catalog | |
| Target |
β3-adrenergic receptor[1] |
| In Vivo | BRL37344 sodium (BRL 37344A) treatment significantly lowers the body weight of obese mice[1]. Animal Model: Five-week-old male Imprinting Control Region (ICR) mice[1] Dosage: 2.5 mg/kg Administration: Intraperitoneal injection; three times per week for two weeks Result: Lowered the body weight of obese mice. |
| References |
| Boiling Point | 569.7ºC at 760mmHg |
|---|---|
| Molecular Formula | C19H21ClNNaO4 |
| Molecular Weight | 385.81700 |
| Flash Point | 298.4ºC |
| Exact Mass | 385.10600 |
| PSA | 81.62000 |
| LogP | 2.11380 |
| Vapour Pressure | 8.09E-14mmHg at 25°C |
| Safety Phrases | S22-S24/25 |
|---|